Trial intelligence / Profile preview

Acupuncture Treatment for Alzheimer's Disease

NCT03810794Recruiting

Start
Mar 2019
Primary completion
Dec 2026
Countries
1
01

Overview

Randomised, single-blind trial in Alzheimer's disease (AD) (2 arms). Primary endpoint: Alzheimer's Disease Assessment Scale-cognition at 12 weeks. Started Mar 2019; status: recruiting.

02

Conditions

Alzheimer's disease (AD)

Beyond the preview

Go deeper on NCT03810794.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03810794.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call